3035.TW | Faraday Technology Corporation Annual &

Annual Balance Sheets

(In TWD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	13.41 Billion	13.51 Billion	12.03 Billion	8.19 Billion	7.7 Billion	6.81 Billion
Total Current Assets	8.87 Billion	9.75 Billion	7.39 Billion	4.7 Billion	5.02 Billion	4.39 Billion
Cash And Short Term Investments	5.74 Billion	4.89 Billion	4.78 Billion	3.07 Billion	2.79 Billion	2.41 Billion
Cash and Cash Equivalents	5.71 Billion	4.87 Billion	4.76 Billion	3.04 Billion	2.77 Billion	2.38 Billion
Short Term Investments	29.59 Million	21.88 Million	26.29 Million	23.49 Million	22.01 Million	25.52 Million
Net Receivables	1.75 Billion	1.63 Billion	1.09 Billion	948.56 Million	1.42 Billion	1.29 Billion
Inventory	1.18 Billion	3.01 Billion	1.32 Billion	500.63 Million	634.55 Million	596.01 Million
Other Current Assets	188.56 Million	204.78 Million	191.14 Million	181.23 Million	163.18 Million	88.65 Million
Total Non-Current Assets	4.54 Billion	3.75 Billion	4.64 Billion	3.49 Billion	2.67 Billion	2.42 Billion
Net PPE	863.83 Million	769.85 Million	729.3 Million	773.59 Million	831.3 Million	575.85 Million
Good Will And Intangible Assets	683.28 Million	614.98 Million	505.04 Million	259.25 Million	550.56 Million	691.47 Million
Good Will	-	-	-	1.00	-	-
Intangible Assets	683.28 Million	614.98 Million	505.04 Million	259.25 Million	550.56 Million	691.47 Million
Long-Term Investments	2.66 Billion	2 Billion	3.07 Billion	2.23 Billion	1.22 Billion	1.07 Billion
Tax Assets	108.69 Million	47.34 Million	26.3 Million	48.77 Million	41.76 Million	47.34 Million
Other Non Current Assets	225.26 Million	325.24 Million	305.16 Million	176.37 Million	29.43 Million	32.4 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	3.56 Billion	4.54 Billion	3.88 Billion	1.85 Billion	2.43 Billion	2 Billion
Total Current Liabilities	3.23 Billion	4.15 Billion	3.5 Billion	1.61 Billion	2.07 Billion	1.76 Billion
Account Payables	998.78 Million	1.12 Billion	1.37 Billion	644.71 Million	1.08 Billion	809.25 Million
Tax Payables	433.64 Million	450.23 Million	171.16 Million	50.34 Million	75.55 Million	63.97 Million
Short Term Debt	124.12 Million	177.1 Million	18.35 Million	32.57 Million	33.9 Million	4000.00
Deferred Revenue	2.08 Billion	1.45 Billion	2.1 Billion	920.59 Million	949.76 Million	63.97 Million
Other Current Liabilities	23.21 Million	1.39 Billion	10.85 Million	16.19 Million	14.51 Million	892.94 Million
Total Non Current Liabilities	327.68 Million	388.33 Million	375.52 Million	244.07 Million	360.17 Million	237.18 Million
Long-Term Debt	199.67 Million	217.37 Million	200.59 Million	209.83 Million	231.44 Million	-
Deferred Revenue Non Current	-	-	-	2.71 Million	4.75 Million	7.03 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	92.64 Million	148.82 Million	166.33 Million	24.71 Million	118.52 Million	227.75 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	9.85 Billion	8.96 Billion	8.15 Billion	6.34 Billion	5.26 Billion	4.81 Billion
Stock Holders Equity	9.53 Billion	8.59 Billion	7.83 Billion	6.29 Billion	5.2 Billion	4.79 Billion
Common Stock	2.48 Billion	2.48 Billion	2.48 Billion	2.48 Billion	2.48 Billion	2.48 Billion
Retained Earnings	3.36 Billion	3.26 Billion	1.72 Billion	491.08 Million	377.13 Million	599.14 Million
Accumulated other comprehensive income	2.98 Billion	2.14 Billion	2.92 Billion	2.59 Billion	1.61 Billion	1.08 Billion
Common Stock Equity	9.53 Billion	8.59 Billion	7.83 Billion	6.29 Billion	5.2 Billion	4.79 Billion
Capital Lease Obligation	228.91 Million	267.24 Million	218.94 Million	242.41 Million	265.34 Million	-
Total Investments	2.69 Billion	2.02 Billion	3.1 Billion	2.26 Billion	1.24 Billion	1.09 Billion
Total Debt	323.79 Million	394.48 Million	218.95 Million	242.41 Million	265.34 Million	4000.00
Net Debt	-5.39 Billion	-4.47 Billion	-4.54 Billion	-2.8 Billion	-2.51 Billion	-2.38 Billion

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3
Total Assets	18.42 Billion	18.32 Billion	18.13 Billion	13.41 Billion	13.41 Billion	13.47 Billion
Total Current Assets	10.9 Billion	12.34 Billion	12.55 Billion	8.87 Billion	8.87 Billion	9.11 Billion
Cash And Short Term Investments	8.39 Billion	9.97 Billion	10.05 Billion	5.74 Billion	5.74 Billion	5.56 Billion
Cash and Cash Equivalents	8.31 Billion	9.9 Billion	9.94 Billion	5.71 Billion	5.71 Billion	5.54 Billion
Short Term Investments	72.98 Million	70.71 Million	113.48 Million	29.59 Million	29.59 Million	21.38 Million
Net Receivables	1.4 Billion	1.18 Billion	1.03 Billion	1.75 Billion	1.75 Billion	1.71 Billion
Inventory	841.59 Million	929.47 Million	955.7 Million	1.18 Billion	1.18 Billion	1.63 Billion
Other Current Assets	1.66 Billion	255.12 Million	505.47 Million	188.56 Million	188.56 Million	195.97 Million
Total Non-Current Assets	7.52 Billion	5.97 Billion	5.58 Billion	4.54 Billion	4.54 Billion	4.35 Billion
Net PPE	1.18 Billion	1.03 Billion	969.25 Million	863.83 Million	863.83 Million	863.73 Million
Good Will And Intangible Assets	2.28 Billion	1.83 Billion	1.59 Billion	683.28 Million	683.28 Million	759.93 Million
Good Will	275.82 Million	275.82 Million	196.36 Million	-	-	-
Intangible Assets	2.01 Billion	1.55 Billion	1.4 Billion	683.28 Million	683.28 Million	759.93 Million
Long-Term Investments	3.77 Billion	2.77 Billion	2.64 Billion	2.66 Billion	2.66 Billion	2.4 Billion
Tax Assets	89.58 Million	96.73 Million	102.24 Million	108.69 Million	108.69 Million	99.05 Million
Other Non Current Assets	190.57 Million	239.58 Million	269.28 Million	225.26 Million	225.26 Million	228.56 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	4.9 Billion	5.16 Billion	4.2 Billion	3.56 Billion	3.56 Billion	4.14 Billion
Total Current Liabilities	3.88 Billion	4.46 Billion	3.5 Billion	3.23 Billion	3.23 Billion	3.76 Billion
Account Payables	1.41 Billion	1.26 Billion	1.09 Billion	998.78 Million	998.78 Million	1.37 Billion
Tax Payables	227.95 Million	286.25 Million	467.23 Million	433.64 Million	433.64 Million	353.13 Million
Short Term Debt	25 Million	83.65 Million	131.19 Million	124.12 Million	124.12 Million	259.85 Million
Deferred Revenue	915.5 Million	852.4 Million	935.71 Million	2.08 Billion	2.08 Billion	2.09 Billion
Other Current Liabilities	1.53 Billion	2.26 Billion	1.34 Billion	23.21 Million	23.21 Million	36.4 Million
Total Non Current Liabilities	1.01 Billion	697.37 Million	694.39 Million	327.68 Million	327.68 Million	370.8 Million
Long-Term Debt	-	250.75 Million	205.02 Million	199.67 Million	199.67 Million	201.25 Million
Deferred Revenue Non Current	-	-	-1.00	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	893.74 Million	329.94 Million	353 Million	92.64 Million	92.64 Million	137.97 Million
Other Liabilities	-	-	1.00	-	-	-
Total Equity	13.52 Billion	13.15 Billion	13.93 Billion	9.85 Billion	9.85 Billion	9.33 Billion
Stock Holders Equity	13.15 Billion	12.81 Billion	13.6 Billion	9.53 Billion	9.53 Billion	8.99 Billion
Common Stock	2.6 Billion	2.6 Billion	2.6 Billion	2.48 Billion	2.48 Billion	2.48 Billion
Retained Earnings	2.88 Billion	2.73 Billion	3.74 Billion	3.36 Billion	3.36 Billion	3.04 Billion
Accumulated other comprehensive income	3.33 Billion	3.25 Billion	3.03 Billion	2.98 Billion	2.98 Billion	2.76 Billion
Common Stock Equity	13.15 Billion	12.81 Billion	13.6 Billion	9.53 Billion	9.53 Billion	8.99 Billion
Capital Lease Obligation	408.62 Million	250.75 Million	205.02 Million	228.91 Million	228.91 Million	237.42 Million
Total Investments	3.77 Billion	2.84 Billion	2.76 Billion	2.69 Billion	2.69 Billion	2.42 Billion
Total Debt	25 Million	334.4 Million	336.21 Million	323.79 Million	323.79 Million	461.1 Million
Net Debt	-8.29 Billion	-9.56 Billion	-9.6 Billion	-5.39 Billion	-5.39 Billion	-5.08 Billion

Balance Sheet Charts

Brighthouse Financial, Inc.

BHF

Full Analysis

Annual Balance Sheets
Sampo Oyj

SAXPY

Full Analysis

Annual Balance Sheets
Kitron ASA

0F0J

Full Analysis

Annual Balance Sheets
ESSA Pharma Inc.

EPIX

Full Analysis

Annual Balance Sheets
Cosmo Pharmaceuticals N.V.

0RGI

Full Analysis

Annual Balance Sheets
Global PMX Co., Ltd.

4551

Full Analysis

Annual Balance Sheets

Global Stocks Search

Faraday Technology Corporation (3035.TW)

Annual Balance Sheets

Balance Sheet Charts

Brighthouse Financial, Inc.

Sampo Oyj

Kitron ASA

ESSA Pharma Inc.

Cosmo Pharmaceuticals N.V.

Global PMX Co., Ltd.